NCT04422431
Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840 treatment 2 completed NCT05047523
Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease No drug interventions treatment 3 terminated NCT05444127
Oral Health and Wilson's Disease: SOMAWI No drug interventions Not Available Not Available recruiting NCT06650319
A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients with Wilson Disease No drug interventions treatment 0 enrolling_by_invitation NCT06573723
Institutional Registry of Rare Diseases No drug interventions Not Available Not Available recruiting NCT05686564
Early Access Program for ALXN1840 in Patients With Wilson Disease Not Available Not Available no_longer_available NCT05783687
Real World Evidence Study in Subjects With Wilson's Disease No drug interventions Not Available Not Available active_not_recruiting NCT04884815
Study of UX701 Gene Transfer for the Treatment of Wilson Disease No drug interventions treatment 1 / 2 active_not_recruiting NCT03539952
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease treatment 3 completed NCT04408300
Study of Retinal Vascular Parameters in Patients With Wilson's Disease No drug interventions other Not Available completed NCT00004339
Study of Tetrathiomolybdate in Patients With Wilson Disease treatment 3 completed NCT01472874
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease treatment Not Available completed NCT03589820
Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure No drug interventions treatment Not Available unknown_status NCT03334292
Natural History of Wilson Disease No drug interventions Not Available Not Available recruiting NCT04910581
rTMS in Wilson Disease Dysarthria No drug interventions treatment Not Available completed NCT03655223
Early Check: Expanded Screening in Newborns No drug interventions Not Available Not Available enrolling_by_invitation NCT00004338
Study of Zinc for Wilson Disease treatment 4 completed NCT01980433
Inhibitory rTMS in Dystonic Wilson Patients No drug interventions treatment Not Available completed NCT04965545
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease No drug interventions Not Available Not Available recruiting NCT03403205
Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease treatment 3 terminated NCT02426905
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine treatment 4 unknown_status NCT04526197
Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants. treatment 1 completed NCT05641311
Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants No drug interventions basic_science 1 completed NCT04965571
Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients No drug interventions Not Available Not Available completed NCT04573309
Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840 No drug interventions treatment 2 completed NCT02763215
The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment No drug interventions Not Available Not Available completed NCT06430359
Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients No drug interventions Not Available Not Available not_yet_recruiting NCT02273596
Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients No drug interventions treatment 2 completed NCT03867526
Establishment of Human Cellular Disease Models for Wilson Disease No drug interventions Not Available Not Available completed NCT05687474
Baby Detect : Genomic Newborn Screening No drug interventions Not Available Not Available recruiting NCT03659331
A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease No drug interventions treatment Not Available unknown_status NCT05231876
Wilson France Register No drug interventions Not Available Not Available recruiting NCT06179394
Evaluation of Cognitive Dysfunction and Psychiatric Comorbidities No drug interventions Not Available Not Available not_yet_recruiting NCT06466291
Spanish Wilson Disease Registry No drug interventions Not Available Not Available recruiting NCT04531189
Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease No drug interventions Not Available Not Available completed NCT04909346
Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson Disease No drug interventions Not Available Not Available terminated NCT04526210
Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants treatment 1 completed NCT05183165
Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease No drug interventions other Not Available recruiting NCT04537377
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease No drug interventions treatment 1 / 2 recruiting NCT04012658
A Registered Cohort Study on Wilson's Disease No drug interventions Not Available Not Available recruiting NCT02702765
sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis diagnostic Not Available completed NCT03957720
The Individual Therapy for Patients With Wilson's Disease treatment 0 recruiting NCT04212195
Cohort Research on Wilson's Disease No drug interventions Not Available Not Available unknown_status NCT00212355
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. No drug interventions treatment 3 completed NCT06128954
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily). treatment 1 completed NCT05493605
Cardiac Involvement in Wilson's Disease No drug interventions other Not Available recruiting NCT02552628
WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation) No drug interventions treatment Not Available completed NCT01874028
A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients treatment 1 completed NCT06051734
Early Detection of Cardiac Affection in Patients of Wilson's Disease No drug interventions Not Available Not Available not_yet_recruiting NCT05239858
International Wilson's Disease Patient Registry (iWilson Registry) No drug interventions Not Available Not Available recruiting NCT01378182
Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis No drug interventions treatment Not Available completed NCT02252380
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders No drug interventions treatment Not Available active_not_recruiting NCT05305872
Gandouling in the Treatment of Wilson's Disease treatment 4 recruiting